- Investing Ideas
- Israeli Pharmaceuticals & Biotech Potentially Undervalued Companies
Israeli Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
7
Companies with a Value score of at least 3, ordered by Value score
7 companies
Tikun Olam-Cannbit Pharmaceuticals
Market Cap: ₪1.1m
Engages in the production, supply, and marketing of cannabis-based products for medical use in Israel.
TKUN-M
₪675.00
7D
1.7%
1Y
-96.4%
Compugen
Market Cap: ₪271.9m
A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.
CGEN
₪8.61
7D
18.9%
1Y
76.2%
InterCure
Market Cap: ₪193.5m
Engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.
INCR
₪17.69
7D
33.3%
1Y
-36.1%
Rafa Laboratories
Market Cap: ₪1.6b
A pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel.
RAFA
₪15.91
7D
9.9%
1Y
n/a
Kamada
Market Cap: ₪1.5b
Manufactures and sells plasma-derived protein therapeutics.
KMDA
₪25.33
7D
9.7%
1Y
7.5%
Seach Medical Group
Market Cap: ₪88.0m
Manufactures and sells medicinal cannabis products worldwide.
SEMG
₪2.74
7D
-1.2%
1Y
-3.1%
BioLineRx
Market Cap: ₪36.7m
A biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.
BLRX
₪0.014
7D
-6.7%
1Y
-33.3%